Asmita Magotra Selected Research

IIIM-MCD-211

1/2018	Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
8/2017	Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Asmita Magotra Research Topics

Disease

2	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 04/2022
2	Neoplasms (Cancer) 05/2022 - 05/2016
2	Colonic Neoplasms (Colon Cancer) 05/2022 - 04/2022
1	Polyps 05/2022
1	Hemolysis 11/2019
1	Virus Diseases (Viral Diseases) 10/2018
1	Chronic Hepatitis C 10/2018
1	Oral Tuberculosis 01/2018
1	Persistent Infection 01/2018
1	Infections 01/2018
1	Inflammation (Inflammations) 12/2017
1	Tuberculosis (Tuberculoses) 08/2017
1	Breast Neoplasms (Breast Cancer) 05/2016

Drug/Important Bio-Agent (IBA)

2	boswellic acidIBA 05/2022 - 04/2022
2	IIIM-MCD-211IBA 01/2018 - 08/2017
2	PiperazineIBA 01/2018 - 08/2017
1	AcidsIBA 05/2022
1	CytokinesIBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	MethyltransferasesIBA 05/2022
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 05/2022
1	Fluorouracil (Carac)FDA LinkGeneric 04/2022
1	ProdrugsIBA 11/2019
1	daclatasvirIBA 10/2018
1	IS01957IBA 12/2017
1	Carbamazepine (Tegretol)FDA LinkGeneric 08/2017
1	withaferin AIBA 05/2016
1	CateninsIBA 05/2016

Therapy/Procedure

2	Therapeutics 04/2022 - 01/2018